Cialis, the erectile dysfunction (ED) drug, may also be beneficial in helping men who have problems with ejaculation and orgasm, say researchers.
Cialis is currently approved for the treatment of ED, benign prostate hypertrophy (BPH) and for treatment of men with both conditions.
A study by researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center, concluded that approximately 70 percent of men who used Cialis during sexual activity for 12 weeks were able to ejaculate most of the time and to reach orgasm, compared to 30 percent in the placebo group. Also, these benefits from the drug were seen despite the level of a man”s ED severity.
“There are many men who have, at most, very mild problems achieving an erection but who cannot easily ejaculate,” said the study”s lead author, Dr. Darius Paduch, a urologist and male sexual medicine specialist at NewYork-Presbyterian/Weill Cornell and director of Sexual Health and Medicine at Weill Cornell Medical College.
“Our study shows Cialis works very well for these men with problems ejaculating,” he added.
In this new study, Dr. Paduch and his colleagues examined data from 17 placebo-controlled 12-week trials of Cialis, given at different doses. These studies included 3,581 participants with a mean age of 54.9, including 1,512 men with severe ejaculatory dysfunction (EJD) and 1,812 with severe orgasmic dysfunction (OD). In some cases, patients with one or both of these conditions reported only mild or moderate ED.
The researchers examined the study participants” responses on questionnaires about the effect Cialis had on ED, EJD, and OD, among other measures of sexual satisfaction. The original questionnaire was primarily focused on the effects of Cialis on ED, but provided valuable additional information.
They found that treatment with Cialis (10 or 20 milligrams taken as needed) was associated with significant increase in ejaculatory and orgasmic function across all levels of severity of ED, EJD and OD, compared to use of a placebo agent.
For example, 66 percent of men with severe EJD and 66 percent with severe OD who used Cialis reported improved ejaculatory function, compared with 36 percent and 35 percent, respectively, in the placebo group. Also, patients with moderate dysfunction also experienced significant improvements with Cialis, Dr. Paduch reported.
“More study is needed, but we are hopeful our findings may lead to a treatment for many men who cannot now achieve sexual satisfaction,” Dr. Paduch said.
The finding has been reported in the February issue of the British Journal of Urology International. (ANI)